medroxyprogesterone has been researched along with Coronary Vasospasm in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abe, H; Nakagawa, T; Nishino, M; Ohnishi, S; Tanahashi, H; Yamada, Y; Yasuno, M | 1 |
Hermsmeyer, K; Miyagawa, K; Rösch, J; Stanczyk, F | 1 |
1 review(s) available for medroxyprogesterone and Coronary Vasospasm
Article | Year |
---|---|
A case of acute myocardial infarction. Intracoronary thrombosis in two major coronary arteries due to hormone therapy.
Topics: Acetylcholine; Coronary Angiography; Coronary Thrombosis; Coronary Vasospasm; Electrocardiography; Emergencies; Female; Humans; Medroxyprogesterone; Middle Aged; Myocardial Infarction; Postoperative Care; Tamoxifen; Tissue Plasminogen Activator | 1994 |
1 other study(ies) available for medroxyprogesterone and Coronary Vasospasm
Article | Year |
---|---|
Medroxyprogesterone interferes with ovarian steroid protection against coronary vasospasm.
Topics: Animals; Coronary Vasospasm; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Macaca mulatta; Medroxyprogesterone; Ovariectomy; Progesterone; Progesterone Congeners; Risk Factors | 1997 |